Talking Stocks 2.0

[Xelorpepsi]

Hi all,

As mentioned earlier in this thread, I like the idea of building a stock portfolio with a focus on specific verticals. As I am based in the UK, I do not have access to a number of ETF available to US investors such as ARKG (if I am wrong, please let me know). Over the next few months, I would like to build positions both in BioTech and Cybersecurity and would love your insight - this is not investment advice and I will do my own due diligence, but any guidance would be immensely appreciated. If you are aware of ETF I could invest in, that would be great too.

BioTech
Gene / DNA editing: BEAM, CRSP, NTLA, EDIT
Bio manufacturing: SRNG, ZY
Proteonomics: CAPA, CMII
Data: CMLF, RXRX, SDGR, NVTA
Synthetic bio: TWST
Liquid biopsy: EXAS, GH
Other: TMO, TXG

Please note that I do not have a BioTech background, so the input of professionals in these fields would be extremely valuable.

In terms of cybersecurity, I can only think of three names ZS & CRWD for cloud security, and KNBE.

Thanks in advance!

[logo]

Originally Posted by Xelorpepsi

Hi all,

As mentioned earlier in this thread, I like the idea of building a stock portfolio with a focus on specific verticals. As I am based in the UK, I do not have access to a number of ETF available to US investors such as ARKG (if I am wrong, please let me know). Over the next few months, I would like to build positions both in BioTech and Cybersecurity and would love your insight - this is not investment advice and I will do my own due diligence, but any guidance would be immensely appreciated. If you are aware of ETF I could invest in, that would be great too.

BioTech
Gene / DNA editing: BEAM, CRSP, NTLA, EDIT
Bio manufacturing: SRNG, ZY
Proteonomics: CAPA, CMII
Data: CMLF, RXRX, SDGR, NVTA
Synthetic bio: TWST
Liquid biopsy: EXAS, GH
Other: TMO, TXG

Please note that I do not have a BioTech background, so the input of professionals in these fields would be extremely valuable.

In terms of cybersecurity, I can only think of three names ZS & CRWD for cloud security, and KNBE.

Thanks in advance!

For cybersecurity, look into NET. The company is on fire in terms of growth and product development. Conference call last week the ceo basically said they were chewing apart ZS. BB is another option as one of the few to focus on IoT cybersecurity. Previously had a position, but it became a bit meme-ish. It’s settled now, in a reasonable valuation I’d say. I’m keeping an eye on it.

I work in Medicine and AI/ML so if you have specific questions I can provide my thoughts, but I do not have any specific knowledge of the companies you’ve outlined for biotech/data.

[scarlet knight]

I own FTNT for cyber security. I own TMO, ILMN in scientific research. YMMV.

[beshannon]

Originally Posted by Xelorpepsi

Hi all,

As mentioned earlier in this thread, I like the idea of building a stock portfolio with a focus on specific verticals. As I am based in the UK, I do not have access to a number of ETF available to US investors such as ARKG (if I am wrong, please let me know). Over the next few months, I would like to build positions both in BioTech and Cybersecurity and would love your insight - this is not investment advice and I will do my own due diligence, but any guidance would be immensely appreciated. If you are aware of ETF I could invest in, that would be great too.

BioTech
Gene / DNA editing: BEAM, CRSP, NTLA, EDIT
Bio manufacturing: SRNG, ZY
Proteonomics: CAPA, CMII
Data: CMLF, RXRX, SDGR, NVTA
Synthetic bio: TWST
Liquid biopsy: EXAS, GH
Other: TMO, TXG

Please note that I do not have a BioTech background, so the input of professionals in these fields would be extremely valuable.

In terms of cybersecurity, I can only think of three names ZS & CRWD for cloud security, and KNBE.

Thanks in advance!

I tried researching your list and stopped after a while because these all look like startups/thinly traded companies with little to no earnings. One was a SPAC which I would never invest in.

Good luck.

[Chromosome]

Originally Posted by Xelorpepsi

Hi all,

As mentioned earlier in this thread, I like the idea of building a stock portfolio with a focus on specific verticals. As I am based in the UK, I do not have access to a number of ETF available to US investors such as ARKG (if I am wrong, please let me know). Over the next few months, I would like to build positions both in BioTech and Cybersecurity and would love your insight - this is not investment advice and I will do my own due diligence, but any guidance would be immensely appreciated. If you are aware of ETF I could invest in, that would be great too.

BioTech
Gene / DNA editing: BEAM, CRSP, NTLA, EDIT
Bio manufacturing: SRNG, ZY
Proteonomics: CAPA, CMII
Data: CMLF, RXRX, SDGR, NVTA
Synthetic bio: TWST
Liquid biopsy: EXAS, GH
Other: TMO, TXG

Please note that I do not have a BioTech background, so the input of professionals in these fields would be extremely valuable.

In terms of cybersecurity, I can only think of three names ZS & CRWD for cloud security, and KNBE.

Thanks in advance!

Don't buy EXAS. The future of liquid biopsy uses blood samples not stool samples.

[Xelorpepsi]

Originally Posted by logo

For cybersecurity, look into NET. The company is on fire in terms of growth and product development. Conference call last week the ceo basically said they were chewing apart ZS. BB is another option as one of the few to focus on IoT cybersecurity. Previously had a position, but it became a bit meme-ish. It’s settled now, in a reasonable valuation I’d say. I’m keeping an eye on it.

I work in Medicine and AI/ML so if you have specific questions I can provide my thoughts, but I do not have any specific knowledge of the companies you’ve outlined for biotech/data.

I had the choice between FSLY and NET and obviously went for the former... Been following NET for a while and really think the valuation is uber stretched, but will keep it on my radar.

Thank you so much for your offer!

Originally Posted by scarlet knight

I own FTNT for cyber security. I own TMO, ILMN in scientific research. YMMV.

I will look into these companies. Thank you!

Originally Posted by beshannon

I tried researching your list and stopped after a while because these all look like startups/thinly traded companies with little to no earnings. One was a SPAC which I would never invest in.

Good luck.

Rightly or wrongly, my assumption is that the BioTech space will grow significantly over the next 10-20 years (at least that's what I have seen for the past decade at the ange & VC level), so it does not surprise to see lots of fairly small companies at this stage. The idea is to pick good / decent candidates, and trim or add over time. Not pretending I will only select winners, but I tend to believe it's easier to learn once you are invested.

Originally Posted by Chromosome

Don't buy EXAS. The future of liquid biopsy uses blood samples not stool samples.

Great insight! Much appreciated!

As always, thank you all for your advice and help!

On a related note, let's see what happens after the release of the new CPI data. Should be interesting!

[logo]

Price action on UP has been nothing short of frustrating. Getting shorted to oblivion. Earnings today were fantastic, however. Revenue up 113% YoY, on pace for over $1B in revenue this year (and their market cap only has them at a $2B valuation). They also state that recovery has been faster than expected (hopefully also boding well for our SABR holders).

Here is the investor presentation from today: https://s27.q4cdn.com/682800059/file...ides-FINAL.pdf

Holding on tight to my shares, would not be surprised to see new analyst ratings come out soon - eventually this WILL go UP, and I believe current prices are a bargain.

[huncho]

Originally Posted by logo

Price action on UP has been nothing short of frustrating. Getting shorted to oblivion. Earnings today were fantastic, however. Revenue up 113% YoY, on pace for over $1B in revenue this year (and their market cap only has them at a $2B valuation). They also state that recovery has been faster than expected (hopefully also boding well for our SABR holders).

Here is the investor presentation from today: https://s27.q4cdn.com/682800059/file...ides-FINAL.pdf

Holding on tight to my shares, would not be surprised to see new analyst ratings come out soon - eventually this WILL go UP, and I believe current prices are a bargain.

price action on a lot of stocks doesn't seem to make sense lately. lot of actual good companies that are making money and growing but their stocks are flat or going down. let's see what happens with sofi tonight lol

[logo]

Well, very nice ER but SOFI after hours movement sure feels like repetitive kicks to the groin. Will be worth it long term though.

[huncho]

Originally Posted by logo

Well, very nice ER but SOFI after hours movement sure feels like repetitive kicks to the groin. Will be worth it long term though.

business as usual with earnings it seems, but the bright side is their earnings call is at 5 so there's still a bit of hope that the after hours move swings back

nvm, looks like it's not reversing. all the growth looks to be overshadowed by the net income loss due to the galileo acquisition. was hoping the guidance would help shake that off

[BroncoOne]

Originally Posted by Xelorpepsi

Hi all,

As mentioned earlier in this thread, I like the idea of building a stock portfolio with a focus on specific verticals. As I am based in the UK, I do not have access to a number of ETF available to US investors such as ARKG (if I am wrong, please let me know). Over the next few months, I would like to build positions both in BioTech and Cybersecurity and would love your insight - this is not investment advice and I will do my own due diligence, but any guidance would be immensely appreciated. If you are aware of ETF I could invest in, that would be great too.

BioTech
Gene / DNA editing: BEAM, CRSP, NTLA, EDIT
Bio manufacturing: SRNG, ZY
Proteonomics: CAPA, CMII
Data: CMLF, RXRX, SDGR, NVTA
Synthetic bio: TWST
Liquid biopsy: EXAS, GH
Other: TMO, TXG

Please note that I do not have a BioTech background, so the input of professionals in these fields would be extremely valuable.

In terms of cybersecurity, I can only think of three names ZS & CRWD for cloud security, and KNBE.

Thanks in advance!

Franchised QSR stocks have been a very good investment, and COVID only amplified them and as a bonus, most pay and increase dividends and buybacks.

[logo]

Getting skewered out there today. Nothing a bit of bbq, golf and bourbon can’t fix this weekend. Happy Friday all, and let’s see what next week brings.

[logo]

Been a rough few days. SABR getting punished with the announcement of the $300M follow on offering. Anyone adding here?

COTY earnings coming up and they’ve gotten beaten down the past little bit. Sell off risk I think is not huge, and other beauty brands are trading closer to their ATH. Guidance could be of concern though.

Not sure what I’ll do with these two just yet. Going to think over the weekend.

[huncho]

Originally Posted by logo

Been a rough few days. SABR getting punished with the announcement of the $300M follow on offering. Anyone adding here?

COTY earnings coming up and they’ve gotten beaten down the past little bit. Sell off risk I think is not huge, and other beauty brands are trading closer to their ATH. Guidance could be of concern though.

Not sure what I’ll do with these two just yet. Going to think over the weekend.

at this point i don't really know what to do anymore. everything non tech has been slowly bleeding for 3+ months and averaging down seems to be a never ending activity with no guarantee. covid is seemingly never gonna go away and every day is non stop fear spreading by the media and it feels like the only play is large cap tech because all non growth stocks don't seem to move up even on good news

[Magnum75]

Definitely not adding to what I already have in Sabre, due to the impacts the Delta variant seems to be having.

I did pickup SOFI shares this week to add to my warrants. (Glad I sold half of those when I did).

[spurwar]

Originally Posted by logo

Been a rough few days. SABR getting punished with the announcement of the $300M follow on offering. Anyone adding here?

COTY earnings coming up and they’ve gotten beaten down the past little bit. Sell off risk I think is not huge, and other beauty brands are trading closer to their ATH. Guidance could be of concern though.

Not sure what I’ll do with these two just yet. Going to think over the weekend.

The plays I think we all have should provide sufficient runway to see things turn around. I have been averaging down but am getting a bit heavy in both of these. I did buy a few contracts for SABR this morning but will likely just keep holding until Delta fears slow down. Will be taking a big loss if I cut now but I am hoping to see a rapid reversal at that point (which could still be at least 3-6 months out).

[huncho]

Originally Posted by spurwar

The plays I think we all have should provide sufficient runway to see things turn around. I have been averaging down but am getting a bit heavy in both of these. I did buy a few contracts for SABR this morning but will likely just keep holding until Delta fears slow down. Will be taking a big loss if I cut now but I am hoping to see a rapid reversal at that point (which could still be at least 3-6 months out).

same for me, at this point im down about 30-40% after averaging down the past 3 months on multiple stocks. unless you have unlimited cash there it's kinda hard to keep up and also watching everything else move up at the same time

i do believe it'll work out over the next 1.5 years though, just a matter of how much profit there would be at this point. still confident long term but just painful today

[logo]

Originally Posted by huncho

same for me, at this point im down about 30-40% after averaging down the past 3 months on multiple stocks. unless you have unlimited cash there it's kinda hard to keep up and also watching everything else move up at the same time

i do believe it'll work out over the next 1.5 years though, just a matter of how much profit there would be at this point. still confident long term but just painful today

Yes I agree. I may yet average down further on COTY and SABR as we do have 16 months of runway, but most likely just holding the course for now. In about 2 weeks we should see the other side of the curve from delta variant cases and hopefully some rebound. But yeah, all the small caps and growth are getting hammered, except NET which seems to have become some kind of mutant that doesn’t go down.

For SABR for instance, my $12 calls are at an average in the high $2 range or something like that, and while I could average down heavy to bring it closer to $2, at expiry we are talking about a break even price of $14.00 vs 15.00 - I’m looking for much higher gain than that. Revs were 4B pre covid and currently has a cap of just 3B.

For COTY, I have $12 calls. Primarily I’ll just need to decide whether to sell those and convert to the $10 ones for more downside protection.

[huncho]

Originally Posted by logo

Yes I agree. I may yet average down further on COTY and SABR as we do have 16 months of runway, but most likely just holding the course for now. In about 2 weeks we should see the other side of the curve from delta variant cases and hopefully some rebound. But yeah, all the small caps and growth are getting hammered, except NET which seems to have become some kind of mutant that doesn’t go down.

For SABR for instance, my $12 calls are at an average in the high $2 range or something like that, and while I could average down heavy to bring it closer to $2, at expiry we are talking about a break even price of $14.00 vs 15.00 - I’m looking for much higher gain than that. Revs were 4B pre covid and currently has a cap of just 3B.

For COTY, I have $12 calls. Primarily I’ll just need to decide whether to sell those and convert to the $10 ones for more downside protection.

yeah fortunately though, the profit chart for sabr 12c in the high 2s is still good even now (assuming 2023?). at $15 in jan through may, profit is about 70% to 50% respectively, so definitely room for good profit. but at the same time with these reopening stocks there's a lot of unknown scenarios that can screw them over

the bright side is with the tapering looming, i'm really not willing to touch any tech stocks as they're mostly getting crushed as is anyway. i made some great gains off tech this year but they've all been lost at this point lol

[7sins]

Been out all week on a much needed vacation.

All Jan 2023 calls have 518 days to expiration. Delta fears are wrecking havoc on both SABR and COTY amongst most other SCG stocks along with recovery plays (just like COVID did originally last year). Look at TSA throughput, you aren't seeing a meaningful delta drop-off, https://www.tsa.gov/coronavirus/passenger-throughput, yesterday was almost 2M TSA checkpoint number. When I traveled, LAX was PACKED, Athens where we landed was PACKED. Once we get over this delta hurdle and whatever future variant, this will likely rebound just as it did once covid originally hit when it bottomed at $3.31. I don't have a crystal ball but I do know travel will eventually rebound and SABR provides the mainframe infrastructure. Also remember, in the 8K it is UP TO $300M in common stock offering, that does NOT mean that all $300M has to be issued and also remember there was a dilution in Aug 2020, which did not have a meaningful impact on the big run-up earlier this year. What I don't understand is during their last ER they noted they have over $1.1 billion in cash, so there really was no reason for this dilution unless they are truly worried about this resurgence of COVID as we are seeing more meeting cancelations. Rev hit 420M last quarter, meaningfully higher than previous quarter but yet trades at 30% off those highs. Just my .02 here, it has been certainly frustrating, I have 14 different trades now in this, all underwater except the one from early this morning on $7C. Happy to ride this through 2022, my biggest gains have always been buying when others are overly fearful, a lot can happen in 518 days and have already slotted this for 2022 returns.

COTY should be interesting next week, looking at EL, REV, ELF etc which all massively beat, I suspect they beat top and bottom, all eyes will be on guidance. If there is any uncertainty or negative guidance it is heading lower otherwise there is a big gap for it to run to the upside. From all I have read, both US and European markets received the new Kylie lineup well with most of the line selling out.

[huncho]

Originally Posted by 7sins

Been out all week on a much needed vacation.

All Jan 2023 calls have 518 days to expiration. Delta fears are wrecking havoc on both SABR and COTY amongst most other SCG stocks along with recovery plays. Look at TSA throughput, you aren't seeing a meaningful drop-off, https://www.tsa.gov/coronavirus/passenger-throughput, yesterday was almost 2M TSA checkpoint number. When I traveled, LAX was PACKED, Athens where we landed was PACKED. Once we get over this delta hurdle and whatever future variant, this will likely rebound just as it did once covid originally hit when it bottomed at $3.31. I don't have a crystal ball but I do know travel will eventually rebound and SABR provides the mainframe infrastructure. Also remember, in the 8K it is UP TO $300M in common stock offering, that does NOT mean that all $300M has to be issued and also remember there was a dilution in Aug 2020, which did not have a meaningful impact on the big run-up earlier this year. What I don't understand is during their last ER they noted they have over $1.1 billion in cash, so there really was no reason for this dilution unless they are truly worried about this resurgence of COVID as we are seeing more meeting cancelations. Rev hit 420M last quarter, meaningfully higher than previous quarter but yet trades at 30% off those highs. Just my .02 here, it has been certainly frustrating, I have 14 different trades now in this, all underwater except the one from early this morning on $7C. Happy to ride this through 2022, my biggest gains have always been buying when others are overly fearful or the hardest to make the purchase order.

COTY should be interesting next week, looking at EL, REV, ELF etc which all massively beat, I suspect they beat top and bottom, all eyes will be on guidance. If there is any uncertainty or negative guidance it is heading lower otherwise there is a big gap for it to run to the upside. From all I have read, both US and European markets received the new Kylie lineup well with most of the line selling out.

i 100% agree that travel will not slow down again (barring another lockdown, which i can't see happening). feels like a lot of stocks are just oversold these days on any form of bad news. they move down way faster than up lol. just a bit of unfortunate timing also, with these looking like great buys and then a few months later the delta variant hits, but it will blow over i'm sure. i'm also in baba and lets not even talk about the unfortunate timing in that one....i don't even know if there's an actual bottom there anymore

[7sins]

Originally Posted by huncho

i 100% agree that travel will not slow down again (barring another lockdown, which i can't see happening). feels like a lot of stocks are just oversold these days on any form of bad news. they move down way faster than up lol. just a bit of unfortunate timing also, with these looking like great buys and then a few months later the delta variant hits, but it will blow over i'm sure. i'm also in baba and lets not even talk about the unfortunate timing in that one....i don't even know if that one has a bottom anymore

What is your plan with BABA? I've been watching closely along with TME but haven't started a position. Looks like all the China news is creating some opportunities, even bringing down TSM as fears that China is going to invade Taiwan (yeah right). Challenging to call a bottom here or even where to start a position with such an unknown political variable.

[huncho]

Originally Posted by 7sins

What is your plan with BABA? I've been watching closely along with TME but haven't started a position. Looks like all the China news is creating some opportunities, even bringing down TSM as fears that China is going to invade Taiwan (yeah right). Challenging to call a bottom here or even where to start a position with such an unknown political variable.

i started to get in at around 205 in june with 2023 leaps when it looked like a great buy and then it was all going according to plan as it bounced to 230 but then the news of the crackdown came. i've just been averaging down/opening new leaps on every -5%+ day or so, so yeah i'm down quite a bit there, about 45% right now

i feel like the stock is way oversold and will bounce. i mean seriously, it's lost over 50% of its value since december, imo that's just ridiculous for a company with their financials and growth. so my plan for now is buy the dips and hope to dump the old leaps i bought in june/july at an eventual break even and then just let the new ones i'm buying now ride out. they're all pretty far otm at this point (even the more recent ones i bought) but as long as baba is 200-210 by end of q2 next year i'll break even on the old ones. probably gonna sit down at some point soon and figure out which ones i should roll over into lower strikes so i can maximize profit

from everything i read though, it seems like a lot of the bad news impacts tencent and other companies and not so much baba? or maybe i have to dig deeper lol

[chsu74]

Originally Posted by huncho

i 100% agree that travel will not slow down again (barring another lockdown, which i can't see happening). feels like a lot of stocks are just oversold these days on any form of bad news. they move down way faster than up lol. just a bit of unfortunate timing also, with these looking like great buys and then a few months later the delta variant hits, but it will blow over i'm sure. i'm also in baba and lets not even talk about the unfortunate timing in that one....i don't even know if there's an actual bottom there anymore

Originally Posted by 7sins

What is your plan with BABA? I've been watching closely along with TME but haven't started a position. Looks like all the China news is creating some opportunities, even bringing down TSM as fears that China is going to invade Taiwan (yeah right). Challenging to call a bottom here or even where to start a position with such an unknown political variable.

Folks,

I was born in Taiwan, grew up in the middle east got sent US for boarding school and college, spent the past 25 years doing business with China and experienced this change within China first about 7-8 years back. Hong Kong fell 18 months ago and CCP continues their march.

Below is a link with a clear undertone that China’s direction is not going to reverse course and its future(including financial) is going to be dictated by their political party and no one else.

Be careful…

China calls for curbs on 'excessive' income, encourages wealthy to give back more https://www.cnbc.com/2021/08/18/chin...pyToPasteboard

[huncho]

Originally Posted by chsu74

Folks,

I was born in Taiwan, grew up in the middle east got sent US for boarding school and college, spent the past 25 years doing business with China and experienced this change within China first about 7-8 years back. Hong Kong fell 18 months ago and CCP continues their march.

Below is a link with a clear undertone that China’s direction is not going to reverse course and its future(including financial) is going to be dictated by their political party and no one else.

Be careful…

China calls for curbs on 'excessive' income, encourages wealthy to give back more https://www.cnbc.com/2021/08/18/chin...pyToPasteboard

yeah i know 100% that things are not going to change for the better in china. hopefully it bounces within a year and i can get out and never touch them again. i refuse to touch any other stocks of theirs now though, even with how much they're all down. i just feel like at some point the market has to realize that the valuation is so low that the political fears are worth the risk for some kind of short-med term buy

[huncho]

double post

[yoast]

Can someone help explain to me why CRSR is performing so poorly? Financials seems in good order?
I bought this last Feb thinking I found an undervalued stock of which there aren't many at the moment but its been pretty much downhill ever since. What gives?

[scarlet knight]

Originally Posted by chsu74

Folks,

I was born in Taiwan, grew up in the middle east got sent US for boarding school and college, spent the past 25 years doing business with China and experienced this change within China first about 7-8 years back. Hong Kong fell 18 months ago and CCP continues their march.

Below is a link with a clear undertone that China’s direction is not going to reverse course and its future(including financial) is going to be dictated by their political party and no one else.

Be careful…

China calls for curbs on 'excessive' income, encourages wealthy to give back more https://www.cnbc.com/2021/08/18/chin...pyToPasteboard

It has nothing to do with earnings, company quality, etc.When an authoritarian government exerts control, run for the exits. There is no bounce. Countries like Cuba and Venezuela expropriated entire companies and industries. You can’t invest in a communist economic system if you are a capitalist. I think Chinese stocks are uninvestable. Just a clash of economic systems.

[7sins]

Lots of green today, nice to see a turnaround in a few of our positions. Thought it was an error on my screen when I saw SABR hit 8%+ on the ticker today on good volume (nice gains from the selloff Friday), another 5% on AUPH and small gain on COTY (not seeing much of a run into ER, if this beats with good guidance should see a nice jump). Added to my HZAC warrants today, averaged down to $1.51, these are getting VERY cheap after their last ER showing 32M EBITDA and $115M in Q2 rev (https://www.globenewswire.com/news-r...1-Results.html), I suspect brought down with delta and SPAC fears but vivid seats should be a winner next year IMO.

Great article below on the consumer, worth a quick 5 minute read.


Delta might be hitting economic growth. Retailers aren't feeling the pinch.

Last week, two main stories featured prominently for markets and the economy: data showing the economic recovery slowing down and retailers reporting blowout second quarter results.

In the Morning Brief last week, we covered a slowing housing market, economists cutting their forecasts for GDP growth, and more commentary about the idea of "peak growth" in this recovery cycle. All of which followed an August 13 report on consumer sentiment that revealed a shocking drop in confidence in the early part of this month amid the spread of the Delta variant, and a pickup in inflation.


In the background of these developments, the stock market wavered. But a rally on Friday left the S&P 500 (^GSPC) roughly unchanged on the week, and within shouting distance of record highs. And a quick glance at my colleague Brian Sozzi's reporting gives us a window into the kinds of results retailers churned out that helped buoy investor confidence.

The week began with Walmart's (WMT) earnings beating expectations, as executives told the Street the Delta variant wasn't changing consumer behavior. Target (TGT) followed with a blowout quarter, and commentary that traffic to its stores hadn't been slowing down in recent weeks.


But even as last week's earnings rush moved away from bellwethers like Walmart and Target, the news remained upbeat.


TJX Companies (TJX), which owns TJ Maxx, Marshalls, and HomeGoods, reported second quarter sales that beat estimates, and said sales have been "very strong" in the early part of the third quarter. Results from Foot Locker (FL) also topped expectations, with the company reporting same-store sales that rose nearly 7%, against Street estimates for a more than 1% drop in the second quarter.

Even Macy's (M), which has been a laggard in the retail space for years, reported a blowout quarter while raising its full-year guidance. It also reinstated its dividend after having cut that payout to preserve cash during the early days of the pandemic.

"Through [Thursday], sales are still great," retail expert Jan Rogers Kniffen told Yahoo Finance Live on Friday. "Nobody's talked about sales slowing down in August. People that did say anything about it said August was good."

Kniffen added: "There is nothing wrong with the consumer from the point of view of the ability to spend or the willingness to spend. And so far, they haven't stepped away from my kind of retail. [Consumers] may have stepped away a little bit from restaurants, but they're showing no inclination to stop spending on discretionary retail, apparel, clothes, shoes. All that stuff is going really, really well."

And so just as we've seen financial markets rotate through leadership groups over the last year, we see consumer spending — the driving force of economic growth — rotating from staying at home, to traveling and dining out, and now towards stocking up ahead of the school year.

A trend that seems to be enough for investors to rally behind.

[jaisonline]

Originally Posted by 7sins

Lots of green today, nice to see a turnaround in a few of our positions. Thought it was an error on my screen when I saw SABR hit 8%+ on the ticker today on good volume (nice gains from the selloff Friday), another 5% on AUPH and small gain on COTY (not seeing much of a run into ER, if this beats with good guidance should see a nice jump). Added to my HZAC warrants today, averaged down to $1.51, these are getting VERY cheap after their last ER showing 32M EBITDA and $115M in Q2 rev (https://www.globenewswire.com/news-r...1-Results.html), I suspect brought down with delta and SPAC fears but vivid seats should be a winner next year IMO.
.

I kinda guessed you probably avg’d down today in HZAC Warrants. Ha.

I’ve selling on the Vivid SkyBox platform for about a month now. Will post my thoughts on selling experience when more time is available (at my son’s soccer practice). In a nutshell, they must change many things to chip away at Stubhub and Ticketmaster’s market share especially for non-broker revenue.

Regardless, adding HZAC Warrants at this price is very attractive despite the website’s issue trying to list tickets. Speculation alone will drive up the stock before investors realize it has a very small choice at taking away Stubhub and TicketMaster market share unless they get contracts w/ MLB, NFL, etc…


Sent from my iPhone using Tapatalk